Clinical tryals of tolerability and safety of lyophilic «layfferon», 9 000 000 iu for intramuscular solution with participation of healthy volunteers
Natalia N. Ryndyuk , Zoya I. Ginko , Roman P. Aleynikov , Iliy V. Vasilevich , Vladimir I. Kuzubov , Svetlana V. Usova , Olga N. Muhina , Maryana G. Sharypova , Sergey N. Targonskiy
Journal of Clinical Practice ›› 2010, Vol. 1 ›› Issue (4) : 35 -40.
Clinical tryals of tolerability and safety of lyophilic «layfferon», 9 000 000 iu for intramuscular solution with participation of healthy volunteers
In the article results of clinical tryal of the new drug containing interferon – Layfferon, 9000000 IUintramuscular solution in healthy volunteers are presented.Safety and tolerability of the new dosage of Layfferon was estimated on the basis of supervision over a condition of volunteers, clinical and laboratory inspection within 30 day after introduction of a preparation.As a result of test it has been established, that Layfferone a doze 9 000 000 IUt is safe and tolerated. Study results have allowed to create the instruction on application for new dosage of the drug.
Layfferon / clinical trials / the safety / tolerability
Ryndyuk N.N., Ginko Z.I., Aleynikov R.P., Vasilevich I.V., Kuzubov V.I., Usova S.V., Muhina O.N., Sharypova M.G., Targonskiy S.N.
/
| 〈 |
|
〉 |
PDF
